The Vanguard Group Discloses Stake in Mural Oncology

The Vanguard Group, Inc., has released a Form 8.3 disclosure concerning Mural Oncology plc, an Ireland-based company. This disclosure, dated August 15, 2025, reveals that Vanguard holds a 4.47% interest in Mural Oncology's $0.01 ordinary shares, totaling 771,795 shares. No short positions or cash-settled derivatives were reported.

The document specifies that there have been minor dealings, with a sale of 32 shares at a price of 1.76 USD per unit. The disclosure also confirms the absence of any agreements or arrangements concerning these securities, including indemnity or options that might influence dealings or voting rights.

No supplemental documents were attached to the Form 8.3, and no other parties are involved in this position disclosure under rule 8.3 of the Irish Takeover Panel Act, 1997. Details regarding stock-settled derivatives are not applicable in this instance.